Literature DB >> 22198802

Immature platelet fraction (IPF) determined with an automated method predicts clopidogrel hyporesponsiveness.

Homam Ibrahim1, Srinivas Nadipalli, Timothy DeLao, Sasidhar Guthikonda, Neal S Kleiman.   

Abstract

The mechanisms for the variability in antiplatelet effects of clopidogrel are not elucidated entirely. Immature (reticulated) platelets may modulate the antiplatelet effects of clopidogrel but must be measured using flow cytometry. Whether new automated detection techniques yield similar results is not known. The objectives of the study to evaluate the role of immature platelets assessed by an automated method in response to the antiplatelet effects of clopidogrel. Twenty-nine healthy volunteers had platelet studies performed before and 1 week after 75 mg daily dosing of clopidogrel. Immature platelet fraction (IPF) was determined using an automated particle counter. Subjects were stratified into tertiles based on the IPF. Platelet studies included light transmission aggregometry (LTA), and vasodilator stimulated phosphoprotein phosphorylation (VASP-P) determined by platelet reactivity index (PRI). Baseline platelet aggregation responses to 2, 5 and 20 μM ADP, were similar in all three tertiles, however they were greater in the upper than in the lower tertile of immature platelets after clopidogrel in response to 5 μM ADP (54% vs. 23%, P = 0.02), with concordant trends for the other two concentrations. PRI was also greater in the upper tertile after clopidogrel (71.2% vs. 57.8%, P = 0.04). The frequency of clopidogrel hyporesponsiveness (aggregation >50% in response to 5 μM of ADP) was also higher in the upper tertile when compared to lower tertile, (60%) versus (10%) respectively (P = 0.02). [corrected]. Immature platelets measured using an automated method, are associated with impaired response to antiplatelet effects of clopidogrel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22198802     DOI: 10.1007/s11239-011-0665-7

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  28 in total

1.  Comparison of flow cytometry with the Sysmex XT2000iV automated analyzer for the detection of reticulated platelets in dogs.

Authors:  Alexander Pankraz; Natali Bauer; Andreas Moritz
Journal:  Vet Clin Pathol       Date:  2008-10-28       Impact factor: 1.180

2.  Correlation between immature platelet fraction and reticulated platelets. Usefulness in the etiology diagnosis of thrombocytopenia.

Authors:  Issac Pons; Manuel Monteagudo; Gianni Lucchetti; Luz Muñoz; Granada Perea; Isabel Colomina; Joaquim Guiu; Joaquima Obiols
Journal:  Eur J Haematol       Date:  2010-05-08       Impact factor: 2.997

3.  In vivo biotinylation studies: specificity of labelling of reticulated platelets by thiazole orange and mepacrine.

Authors:  M Robinson; S MacHin; I Mackie; P Harrison
Journal:  Br J Haematol       Date:  2000-03       Impact factor: 6.998

4.  The septic milieu triggers expression of spliced tissue factor mRNA in human platelets.

Authors:  M T Rondina; H Schwertz; E S Harris; B F Kraemer; R A Campbell; N Mackman; C K Grissom; A S Weyrich; G A Zimmerman
Journal:  J Thromb Haemost       Date:  2011-04       Impact factor: 5.824

5.  Dose- and time-dependent antiplatelet effects of aspirin.

Authors:  Christina Perneby; N Håkan Wallén; Cathy Rooney; Desmond Fitzgerald; Paul Hjemdahl
Journal:  Thromb Haemost       Date:  2006-04       Impact factor: 5.249

6.  Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin.

Authors:  S Guthikonda; E I Lev; R Patel; T DeLao; A L Bergeron; J-F Dong; N S Kleiman
Journal:  J Thromb Haemost       Date:  2007-03       Impact factor: 5.824

7.  Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease.

Authors:  E L Grove; A M Hvas; S B Mortensen; S B Larsen; S D Kristensen
Journal:  J Thromb Haemost       Date:  2011-01       Impact factor: 5.824

8.  Immature platelets in patients with acute coronary syndromes.

Authors:  Erik Lerkevang Grove; Anne-Mette Hvas; Steen Dalby Kristensen
Journal:  Thromb Haemost       Date:  2009-01       Impact factor: 5.249

9.  Demonstration that thiazole-orange-positive platelets in the dog are less than 24 hours old.

Authors:  G L Dale; P Friese; L A Hynes; S A Burstein
Journal:  Blood       Date:  1995-04-01       Impact factor: 22.113

Review 10.  Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives.

Authors:  Dominick J Angiolillo; Antonio Fernandez-Ortiz; Esther Bernardo; Fernando Alfonso; Carlos Macaya; Theodore A Bass; Marco A Costa
Journal:  J Am Coll Cardiol       Date:  2007-03-26       Impact factor: 24.094

View more
  19 in total

1.  Immature platelet fraction and high-on treatment platelet reactivity with ticagrelor in patients with acute coronary syndromes.

Authors:  Monica Verdoia; Chiara Sartori; Patrizia Pergolini; Matteo Nardin; Roberta Rolla; Lucia Barbieri; Alon Schaffer; Paolo Marino; Giorgio Bellomo; Harry Suryapranata; Giuseppe De Luca
Journal:  J Thromb Thrombolysis       Date:  2016-05       Impact factor: 2.300

Review 2.  Effects of P2Y12 receptor antagonists beyond platelet inhibition--comparison of ticagrelor with thienopyridines.

Authors:  Sven Nylander; Rainer Schulz
Journal:  Br J Pharmacol       Date:  2016-02-24       Impact factor: 8.739

Review 3.  Obesity and Altered Aspirin Pharmacology.

Authors:  Nicholas B Norgard
Journal:  Clin Pharmacokinet       Date:  2018-06       Impact factor: 6.447

4.  Characterization of surface antigens of reticulated immature platelets.

Authors:  Adi Lador; Dorit Leshem-Lev; Galia Spectre; Aryeh Abelow; Ran Kornowski; Eli I Lev
Journal:  J Thromb Thrombolysis       Date:  2017-10       Impact factor: 2.300

Review 5.  Biomarkers in acute coronary artery disease.

Authors:  Matthias K Freynhofer; Miloš Tajsić; Johann Wojta; Kurt Huber
Journal:  Wien Med Wochenschr       Date:  2012-11-10

6.  Gradual increase in thrombogenicity of juvenile platelets formed upon offset of prasugrel medication.

Authors:  Constance C F M J Baaten; Leo F Veenstra; Rick Wetzels; Johanna P van Geffen; Frauke Swieringa; Susanne M de Witt; Yvonne M C Henskens; Harry Crijns; Sven Nylander; J J J van Giezen; Johan W M Heemskerk; Paola E J van der Meijden
Journal:  Haematologica       Date:  2015-06-25       Impact factor: 9.941

7.  Do immature platelet levels in chest pain patients presenting to the emergency department aid in the diagnosis of acute coronary syndrome?

Authors:  M A Berny-Lang; C E Darling; A L Frelinger; M R Barnard; C S Smith; A D Michelson
Journal:  Int J Lab Hematol       Date:  2014-05-08       Impact factor: 2.877

8.  Impact of diabetes on immature platelets fraction and its relationship with platelet reactivity in patients receiving dual antiplatelet therapy.

Authors:  Monica Verdoia; Patrizia Pergolini; Matteo Nardin; Roberta Rolla; Lucia Barbieri; Alon Schaffer; Paolo Marino; Giorgio Bellomo; Harry Suryapranata; Giuseppe De Luca
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

Review 9.  The effect of in-hospital acquired thrombocytopenia on the outcome of patients with acute coronary syndromes: A systematic review and meta-analysis.

Authors:  Evangelos K Oikonomou; Theodoros I Repanas; Christos Papanastasiou; Damianos G Kokkinidis; Michael Miligkos; Attila Feher; Dipti Gupta; Polydoros N Kampaktsis
Journal:  Thromb Res       Date:  2016-09-24       Impact factor: 3.944

10.  Detection and quantification of circulating immature platelets: agreement between flow cytometric and automated detection.

Authors:  Homam Ibrahim; Srinivas Nadipalli; Saba Usmani; Timothy DeLao; LaShawna Green; Neal S Kleiman
Journal:  J Thromb Thrombolysis       Date:  2016-07       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.